-
公开(公告)号:EP1366066A2
公开(公告)日:2003-12-03
申请号:EP02703926.2
申请日:2002-03-07
发明人: TODA, Ayako,Fujisawa Pharmaceutical Co., Ltd , MIZUNO, Hiroaki,Fujisawa Pharmaceutical Co., Ltd , MATSUYA, Takahiro,Fujisawa Pharmaceutical Co. Ltd , MATSUDA, Hiroshi,Fujisawa Pharmaceutical Co. Ltd , MURANO, Kenji,Fujisawa Pharmaceutical Co. Ltd , BARRETT, David,Fujisawa Pharmaceutical Co. Ltd , OGINO, Takashi,Fujisawa Pharmaceutical Co. Ltd , MATSUDA, Keiji,Fujisawa Pharmaceutical Co. Ltd
摘要: This invention relates to new polypeptide compound represented by the following general formula (I): wherein R?1, R2, R3, R4, R5 and R6¿ are as defined in the description or a salt thereof which has antimicrobial activities (especially, antifungal activities), inhibitory activity on β-1, 3-glucan synthase, to process for preparation thereof, to a pharmaceutical composition comprising the same, and to a method for prophylactic and/or therapeutic treatment of infectious diseases including Pneumocystis carinii infection (e.g. Pneumocystis carinii pneumonia) in a human being or an animal.